MN

Mahesh Nathalal Shah

Director Whole-Time Director DIN 00118341
DIN 00118341 First appointment Dec 1999 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 1999
Shareholding value •••• Premium profile

About Mahesh Nathalal Shah

Data last updated:

Mahesh Nathalal Shah was a Whole-Time Director at Emcure Pharmaceuticals Limited (1999–2016) and Director at Lasor Pharmaceuticals Limited (2009–2010). The companies operate in Pharma and Chemicals.

DIN 00118341
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 11 Dec 1999

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Emcure Pharmaceuticals Limited L24231PN1981PLC024251
Whole-Time Director11 Dec 19991981₹9,216 Cr (FY 2026)Active
Lasor Pharmaceuticals Limited U24232PN2005PLC020815
Director30 Mar 20092005Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Emcure Pharmaceuticals Limited
Lasor Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Mahesh Nathalal Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahesh Nathalal Shah

Mahesh Nathalal Shah was first appointed on 11 Dec 1999 as Whole-Time Director at Emcure Pharmaceuticals Limited. The most recent appointment on record is 30 Mar 2009 at Lasor Pharmaceuticals Limited.

Mahesh Nathalal Shah held 2 earlier board appointments: Emcure Pharmaceuticals Limited (Whole-Time Director, 11 Dec 1999 to 14 Jun 2016); Lasor Pharmaceuticals Limited (Director, 30 Mar 2009 to 04 Feb 2010).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available